Cargando…

Suitability of Polymyxin B as a Mucosal Adjuvant for Intranasal Influenza and COVID-19 Vaccines

Polymyxin B (PMB) is an antibiotic that exhibits mucosal adjuvanticity for ovalbumin (OVA), which enhances the immune response in the mucosal compartments of mice. Frequent breakthrough infections of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants indicate that the IgA antibody...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoshino, Naoto, Yokoyama, Takuya, Sakai, Hironori, Sugiyama, Ikumi, Odagiri, Takashi, Kimura, Masahiro, Hojo, Wataru, Saino, Tomoyuki, Muraki, Yasushi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675063/ https://www.ncbi.nlm.nih.gov/pubmed/38006059 http://dx.doi.org/10.3390/vaccines11111727

Ejemplares similares

Polymyxins as Novel and Safe Mucosal Adjuvants to Induce Humoral Immune Responses in Mice
por: Yoshino, Naoto, et al.
Publicado: (2013)

Mast cells partially contribute to mucosal adjuvanticity of surfactin in mice
por: Yoshino, Naoto, et al.
Publicado: (2017)

A mouse monoclonal antibody against influenza C virus attenuates acetaminophen-induced liver injury in mice
por: Sasaki, Yutaka, et al.
Publicado: (2021)

Development of mucosal adjuvants for intranasal vaccine for H5N1 influenza viruses
por: Hasegawa, Hideki, et al.
Publicado: (2009)

Intranasal influenza vaccination using a new synthetic mucosal adjuvant SF‐10: induction of potent local and systemic immunity with balanced Th1 and Th2 responses
por: Kimoto, Takashi, et al.
Publicado: (2013)

The intranasal adjuvant Endocine™ enhances both systemic and mucosal immune responses in aged mice immunized with influenza antigen
por: Falkeborn, Tina, et al.
Publicado: (2017)

Nano-Encapsulated Melatonin: A Promising Mucosal Adjuvant in Intranasal Immunization against Chronic Experimental T. gondii Infection
por: Said, Doaa E., et al.
Publicado: (2022)

Multicomponent intranasal adjuvant for mucosal and durable systemic SARS-CoV-2 immunity in young and aged mice
por: Jangra, Sonia, et al.
Publicado: (2023)

Cytokines: The Future of Intranasal Vaccine Adjuvants
por: Thompson, Afton L., et al.
Publicado: (2011)

Intranasal Immunization with an Archaeal Lipid Mucosal Vaccine Adjuvant and Delivery Formulation Protects against a Respiratory Pathogen Challenge
por: Patel, Girishchandra B., et al.
Publicado: (2010)

A study of Chitosan and c‐di‐GMP as mucosal adjuvants for intranasal influenza H5N1 vaccine
por: Svindland, Signe C., et al.
Publicado: (2012)

The mucosal and systemic immune responses elicited by a chitosan‐adjuvanted intranasal influenza H5N1 vaccine
por: Svindland, Signe C., et al.
Publicado: (2011)

Nano-Encapsulated Antioxidant: Retinoic Acid as a Natural Mucosal Adjuvant for Intranasal Immunization against Chronic Experimental Toxoplasmosis
por: Said, Doaa E., et al.
Publicado: (2023)

Potentiating Lung Mucosal Immunity Through Intranasal Vaccination
por: Nelson, Sean A., et al.
Publicado: (2021)

Intranasal administration of cationic liposomes enhanced granulocyte–macrophage colony-stimulating factor expression and this expression is dispensable for mucosal adjuvant activity
por: Tada, Rui, et al.
Publicado: (2018)

Use of PELC/CpG Adjuvant for Intranasal Immunization with Recombinant Hemagglutinin to Develop H7N9 Mucosal Vaccine
por: Chen, Ting-Hsuan, et al.
Publicado: (2020)

Intranasal SARS-CoV-2 spike-based immunisation adjuvanted with polyethyleneimine elicits mucosal and systemic humoral responses in mice
por: Deimel, Lachlan P., et al.
Publicado: (2022)

Intranasal nanoemulsion adjuvanted S-2P vaccine demonstrates protection in hamsters and induces systemic, cell-mediated and mucosal immunity in mice
por: Ganesan, Shyamala, et al.
Publicado: (2022)

Comparable efficacy and safety of COVID-19 vaccines for patients receiving tegafur–uracil as postoperative adjuvant chemotherapy
por: Nishikubo, Megumi, et al.
Publicado: (2023)

Mucosal Immunization and Adjuvants
por: Hasegawa, Hideki, et al.
Publicado: (2014)

Holographic Performance of Azo-Carbazole Dye-Doped UP Resin Films Using a Dyeing Process
por: Kinashi, Kenji, et al.
Publicado: (2019)

Characterization of Systemic and Mucosal Humoral Immune Responses to an Adjuvanted Intranasal SARS-CoV-2 Protein Subunit Vaccine Candidate in Mice
por: Maltseva, Mariam, et al.
Publicado: (2022)

Mast cell degranulation is negatively regulated by the Munc13-4-binding small-guanosine triphosphatase Rab37
por: Higashio, Hironori, et al.
Publicado: (2016)

Glucopyranosyl Lipid Adjuvant (GLA), a Synthetic TLR4 Agonist, Promotes Potent Systemic and Mucosal Responses to Intranasal Immunization with HIVgp140
por: Arias, Mauricio A., et al.
Publicado: (2012)

A multicomponent intranasal adjuvant drives durable humoral, cellular, and mucosal immune responses to SARS-CoV-2 in young and aged mice
por: Jangra, Sonia, et al.
Publicado: (2023)

Mucosal vaccine adjuvants update
por: Rhee, Joon Haeng, et al.
Publicado: (2012)

Hemoperfusion with an immobilized polymyxin B fiber column improves gastric mucosal pH with sepsis patients
por: Kushi, H, et al.
Publicado: (2006)

The Difference Between Polymyxin B and Polymyxin E in Causing Skin Hyerpigmentation
por: Zou, Dongna, et al.
Publicado: (2021)

Development of mucosal vaccine delivery: an overview on the mucosal vaccines and their adjuvants
por: Anggraeni, Rahmi, et al.
Publicado: (2022)

Direct hemoperfusion using a polymyxin B‐immobilized polystyrene column for COVID‐19
por: Katagiri, Daisuke, et al.
Publicado: (2020)

Comprehensive immunoprofiling and systematic adjuvant comparisons for identifying suitable vaccine: Adjuvant pairings
por: Vázquez-Maldonado, Nancy, et al.
Publicado: (2023)

Successful Recovery from COVID-19-associated Acute Respiratory Failure with Polymyxin B-immobilized Fiber Column-direct Hemoperfusion
por: Kusaba, Yusaku, et al.
Publicado: (2020)

Polymyxins: To Combine or Not to Combine?
por: Perez, Federico, et al.
Publicado: (2019)

Treatment of HPV-Related Uterine Cervical Cancer with a Third-Generation Oncolytic Herpes Simplex Virus in Combination with an Immune Checkpoint Inhibitor
por: Kagabu, Masahiro, et al.
Publicado: (2023)

Suggestions and tips regarding polymyxin B-immobilized fiber column direct hemoperfusion of neonates with sepsis
por: Nishizaki, Naoto
Publicado: (2020)

CpG oligodeoxynucleotides as mucosal adjuvants
por: Iho, Sumiko, et al.
Publicado: (2015)

Modes of Action for Mucosal Vaccine Adjuvants
por: Aoshi, Taiki
Publicado: (2017)

Systemic and Mucosal Antibody Responses to Soluble and Nanoparticle-Conjugated Antigens Administered Intranasally
por: Howe, Savannah E., et al.
Publicado: (2016)

Unadjuvanted intranasal spike vaccine elicits protective mucosal immunity against sarbecoviruses
por: Mao, Tianyang, et al.
Publicado: (2022)

Intranasal Delivery of Influenza Subunit Vaccine Formulated with GEM Particles as an Adjuvant
por: Saluja, Vinay, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_64mbacarrulg3e73nm3spareo1